Concepedia

G L Scheffer

GL

13

Publications

2K

Citations

13

H-Index

1993

Active since

Affiliations

University of Amsterdam(Current)

Institut Català d'Oncologia

Amsterdam UMC Location Vrije Universiteit Amsterdam

G L Scheffer is an author at University of Amsterdam specializing in tumor biology, medicine, and pharmacology.

Top concepts

Publications per year

1993–2002

13

Publications

13

Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance.

Rik J. Scheper, H J Broxterman, G L Scheffer et al. · PubMed · 1993 · 502 citations

, , +17

Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia

CS Spier, TM Grogan, Charles A. Johnson et al. · Blood · 1996 · 244 citations

Drug Resistance-Associated Marker Lrp for Prediction of Response to Chemotherapy and Prognoses in Advanced Ovarian Carcinoma

M. A. lzquierdo, Ate Gj Van Der Zee, Jan B. Vermorken et al. · JNCI Journal of the National Cancer Institute · 1995 · 223 citations

The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux.

Charles Erlichman, Scott A. Boerner, Christopher G. Hallgren et al. · PubMed · 2001 · 222 citations

, , +15

Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines.

G L Scheffer, Marc Maliepaard, A C Pijnenborg et al. · PubMed · 2000 · 170 citations

, , +17

Rows per page

1–5 of 13